Possible antidepressive effects of opioids: action of buprenorphine.
about
Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on AddictionSynthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor ModulatorsPsychotomimesis mediated by kappa opiate receptorsDo antidepressants cure or create abnormal brain states?Psychotherapeutic benefits of opioid agonist therapy.Evaluation of opioid modulation in major depressive disorderEffect of dehydroepiandrosterone add-on therapy on mood, decision making and subsequent relapse of polydrug users.Major Depressive Disorder and Kappa Opioid Receptor Antagonists.The multi-site prescription opioid addiction treatment study: 18-month outcomesThe dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptorAntidepressant-like effects of buprenorphine in rats are strain dependent.Effects of buprenorphine on responses to social stimuli in healthy adults.Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.Development of κ opioid receptor antagonists.Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.Therapeutic armamentarium for treating depression.Delta opioid agonists: a concise update on potential therapeutic applications.Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in miceKappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.Mania precipitated by opioid withdrawal: a retrospective study.Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.Buprenorphine for the treatment of depression?Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.Delta Opioids: Neuroprotective Roles in Preclinical Studies.Opioids and MotivationThe Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review
P2860
Q26770785-B805A106-D61C-4CDB-8738-4222535533DDQ28275620-F4862BA2-6E93-4170-A29E-60907770DFABQ28287612-334684A5-74CB-471A-A6B5-388E1D96D9CCQ33244689-25CCBA46-298A-4DA6-B513-6866258E9562Q34014407-BD371BC8-1800-4B76-B958-4874E4466584Q34454397-CBE2270E-169F-4498-A9B8-A736678A7CF9Q34469038-9C3EEA61-02BD-4837-972F-BDCD49FF06DDQ34527874-54704989-B517-45CF-9F3E-E40054FAD7D3Q34602946-78DB6886-712C-43AD-9FF7-570DB6EC715EQ34903009-4BDAFD17-C70B-4D7E-AEC6-AAA36B09FDC5Q35182618-A97DA13E-FC75-4AC4-98AD-5495B95E1C43Q35243233-0171E38E-1B18-442F-A5AD-C27957E00C9CQ36414570-849C5702-9E66-466C-8DD8-6789D8008D44Q36441841-7894B480-398B-416B-98BC-9ABB6CF0CF34Q36593892-5C84C60F-C8EC-44B6-AD48-1890BD2EC521Q36728154-B673593C-CACE-441E-8722-CE469D2C408FQ36800122-E8D3114F-9ADB-4B3C-894B-51F835FEB446Q37116421-800136AC-F6CC-4520-A1B4-BB90D14E4DCCQ37235468-2E9B9755-685B-4DDD-91D4-DA9DFEFBED07Q37626594-6C34B063-CA14-40E7-897E-B3F77625E9EAQ37777008-143473DA-8AE7-4C8F-AEF4-60FBDB0F8277Q38366279-0359057F-6640-4684-A3CA-7498790AD9D1Q41537125-891F0844-31DC-4AE6-957E-287CF6CE2113Q41639865-C466D3D6-83C0-405B-B1A8-356FA256302BQ44340034-15BBD872-0071-4D09-AF0E-A2E788065702Q44341273-7909F335-1D90-4310-8110-818508307E7CQ48056551-9546358F-A4BC-44A4-B28C-CD95A28FE730Q48143733-CE5D733A-14ED-42C2-AC75-287002579650Q49925827-34F78D2A-0C5C-4EF7-B18D-DEC6D2E65338Q58443246-8EBC2603-67ED-4380-8F73-2380ECBB9824Q58776450-0E5B85BD-2E7C-47BA-BF66-6B71F92D9937
P2860
Possible antidepressive effects of opioids: action of buprenorphine.
description
1982 nî lūn-bûn
@nan
1982 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Possible antidepressive effects of opioids: action of buprenorphine.
@ast
Possible antidepressive effects of opioids: action of buprenorphine.
@en
Possible antidepressive effects of opioids: action of buprenorphine.
@nl
type
label
Possible antidepressive effects of opioids: action of buprenorphine.
@ast
Possible antidepressive effects of opioids: action of buprenorphine.
@en
Possible antidepressive effects of opioids: action of buprenorphine.
@nl
prefLabel
Possible antidepressive effects of opioids: action of buprenorphine.
@ast
Possible antidepressive effects of opioids: action of buprenorphine.
@en
Possible antidepressive effects of opioids: action of buprenorphine.
@nl
P2093
P2860
P1476
Possible antidepressive effects of opioids: action of buprenorphine.
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1982.TB39483.X
P407
P577
1982-01-01T00:00:00Z